LEADS BIOLABS-B

9887
33.2600.00% ( 0.000 )
Delay

Financials

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: LEADS BIOLABS-B(09887) the Revenue is 20.77 M (--%);the EBIT is -113.44 M (-13.75%);the EPS is -0.651 (-2.07%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.02B--
----
----
EBIT
-0.11B13.75%
----
----
EPS
-0.65052.07%
----
----

Upcoming earnings report - FY2026 Q3 Earning Release

Available dateDec 1, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--

Revenue

ActualEstimateUnit: HKD
Quarterly

EBIT

ActualEstimateUnit: HKD
Quarterly

Net income

ActualEstimateUnit: HKD
Quarterly

EPS

ActualEstimateUnit: HKD
Quarterly